Wyeth Nutritionals: Pfizer’s New MVP, Or Benchwarmer?
This article was originally published in The Tan Sheet
Executive Summary
Wyeth Nutrition could boost Pfizer's revenue outside the U.S. and buffer some upcoming patent losses in its prescription roster through the pending $68 billion deal